Joseph T Woitach

Title: Joseph T Woitach: Innovator in Molecular Biology

Introduction

Joseph T Woitach is a notable inventor based in North Bethesda, MD (US). He has made significant contributions to the field of molecular biology, particularly in the study of gene expression and protein interactions. With a total of 2 patents, his work has implications for understanding cellular mechanisms and potential therapeutic applications.

Latest Patents

Woitach's latest patents include the development of cDNA encoding a gene known as BOG (B5T Over-expressed Gene) and its protein product. This invention provides nucleic acids that encode novel polypeptides designated as 'BOG'. BOG has been shown to bind to pRb and is over-expressed in several transformed rat liver epithelial (RLE) cell lines that are resistant to the growth inhibitory effects of TGF-β1, as well as in primary liver tumors. The patents also describe compositions that include BOG chimeras, nucleic acids encoding BOG, and antibodies to BOG. Furthermore, methods for using BOG to modulate pRb-protein interactions and alter cellular phenotypes are outlined in his patents.

Career Highlights

Joseph T Woitach works for the United States of America, as represented by the Secretary, Department of Health and Human Services. His research has contributed to advancements in understanding the role of specific genes in cancer biology and cellular growth regulation.

Collaborations

Woitach has collaborated with notable colleagues in his field, including Snorri S Thorgeirsson and Minghuang Zhang. These collaborations have likely enhanced the depth and impact of his research.

Conclusion

Joseph T Woitach's innovative work in molecular biology, particularly through his patents related to the BOG gene, showcases his contributions to understanding complex cellular interactions. His research continues to pave the way for potential advancements in therapeutic strategies for cancer and other diseases.